{
  "id": "leber-hereditary-optic-neuropathy",
  "title": "Leber Hereditary Optic Neuropathy",
  "lang": "en",
  "source_lang": "en",
  "summary": "Leber hereditary optic neuropathy is a mitochondrial genetic disorder that causes predominantly central vision loss through degeneration of retinal ganglion cells and the optic nerve.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "LHON",
    "Leber's hereditary optic neuropathy",
    "Leber optic neuropathy"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/leber-hereditary-optic-neuropathy/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/leber-hereditary-optic-neuropathy/",
      "json": "https://aiwiki.page/zh/leber-hereditary-optic-neuropathy.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Leber hereditary optic neuropathy (LHON) is an inherited disorder that causes degeneration of retinal ganglion cells and their nerve fibers, producing painless loss of central vision. It is usually caused by pathogenic variants in mitochondrial DNA and follows maternal inheritance. Vision loss most often begins in adolescence or early adulthood, although onset can occur at other ages. Males are affected more frequently than females, and many people carrying an LHON-associated variant never develop visual impairment."
    },
    {
      "heading": "Clinical features",
      "text": "The characteristic presentation is painless, subacute central vision loss in one eye, followed by involvement of the other eye within weeks or months. Some individuals have simultaneous involvement of both eyes. Early symptoms include blurred central vision, difficulty reading or recognizing faces, and impaired color discrimination.\n\nVisual-field testing typically shows a central or cecocentral scotoma: an area of reduced or absent vision involving fixation and sometimes extending toward the normal blind spot. Peripheral vision is relatively preserved, so severe impairment of reading and detailed visual tasks does not necessarily mean complete loss of sight.\n\nDuring the early phase, examination may reveal small dilated blood vessels around the optic disc, vascular tortuosity, and swelling of the retinal nerve fiber layer. The swelling characteristically lacks the fluorescein leakage expected in some other causes of optic-disc edema. These findings are not present in every affected person. Over time, loss of nerve fibers produces optic-disc pallor and thinning of the retinal nerve fiber and ganglion cell layers.\n\nMost cases predominantly affect vision. Less commonly, additional neurological or cardiac abnormalities occur, sometimes described as “LHON-plus” phenotypes. A multiple-sclerosis-like illness has also been reported in association with LHON, particularly in women; it is not a feature of most cases."
    },
    {
      "heading": "Genetic basis and disease mechanism",
      "text": "Mitochondrial variants\n\nThree mitochondrial variants account for approximately 90% of molecularly diagnosed cases in many studied populations:\n\nMitochondrial DNA variant | Gene\nm.11778G>A | MT-ND4\nm.3460G>A | MT-ND1\nm.14484T>C | MT-ND6\n\nThese genes encode components of respiratory-chain complex I, an enzyme complex involved in oxidative phosphorylation. This process helps generate adenosine triphosphate, a principal carrier of usable energy in cells.\n\nLHON-associated variants impair mitochondrial function. Retinal ganglion cells, particularly those serving central vision through the papillomacular bundle, are especially vulnerable. Their high energy requirements and specialized axonal structure are considered important contributors to this selective vulnerability. Disturbed energy production, oxidative stress, and pathways leading to cell death are implicated, but the full mechanism remains incompletely understood.\n\nRarer mitochondrial variants can also cause LHON. Nuclear genetic causes of LHON-like disease have been identified, including biallelic variants in DNAJC30; these do not follow the usual maternal inheritance pattern of mitochondrial LHON.\n\nInheritance and incomplete penetrance\n\nMitochondrial DNA is normally transmitted through the mother. In mitochondrial LHON, affected or unaffected male carriers do not transmit the causative mitochondrial variant to their children. Female carriers can transmit it to children of either sex.\n\nMany carriers are homoplasmic, meaning that essentially all mitochondrial DNA copies carry the variant. Others are heteroplasmic, carrying a mixture of variant and nonvariant mitochondrial DNA. In heteroplasmic families, the proportion transmitted can differ among children.\n\nInheritance of a pathogenic variant does not guarantee vision loss. This incomplete penetrance varies with sex, age, family background, and other genetic and environmental factors. Consequently, a family may contain several unaffected carriers, and an affected person may have no recognized family history.\n\nSmoking is associated with an increased likelihood of visual loss among carriers. Heavy alcohol exposure has also been investigated as a contributing factor. These associations do not fully explain why disease develops in some carriers but not others, and mitochondrial variant status alone cannot reliably predict an individual’s age at onset or eventual visual outcome."
    },
    {
      "heading": "Diagnosis",
      "text": "Diagnosis combines the clinical pattern, ophthalmic examination, and molecular genetic testing. Identification of a recognized pathogenic mitochondrial variant can confirm the genetic basis of a compatible presentation.\n\nCommon investigations include:\n\n- Visual acuity and color-vision testing, to characterize loss of central visual function.\n- Visual-field testing, to identify central or cecocentral defects.\n- Optical coherence tomography, to measure retinal nerve fiber and ganglion cell layers and document changes over time.\n- Genetic testing, usually beginning with the common mitochondrial variants and expanding when the clinical findings justify further analysis.\n\nMagnetic resonance imaging and laboratory investigations may be used to evaluate alternative explanations, especially when the presentation is atypical. The differential diagnosis includes inflammatory optic neuropathy, compressive lesions, toxic or nutritional optic neuropathy, and other inherited optic nerve disorders.\n\nA positive genetic result in an asymptomatic relative establishes carrier status rather than active optic neuropathy. Interpretation therefore distinguishes the presence of a pathogenic variant from clinical expression of the disease."
    },
    {
      "heading": "Treatment and rehabilitation",
      "text": "Treatment evidence depends on the intervention, disease stage, and underlying variant. Established optic nerve damage is difficult to reverse, and visual recovery is variable.\n\nIdebenone, a synthetic compound related to coenzyme Q10, is authorized in the European Union for visual impairment in adolescents and adults with LHON. Its proposed action involves supporting electron transfer within the mitochondrial respiratory chain. Clinical studies have reported benefit in some patients, but improvement is not universal. Authorization and availability differ between jurisdictions.\n\nGene therapy research has focused particularly on MT-ND4-associated disease. Investigational approaches introduce a functional gene construct into retinal cells using a viral vector. Interpretation of trials has been complicated by visual improvement in both injected and uninjected eyes, alongside variability in the natural course of LHON. Results for a particular construct and genotype cannot automatically be generalized to all forms of the disorder.\n\nVisual rehabilitation addresses persistent functional impairment. It may include magnification, screen-reading software, accessible educational materials, and other assistive technologies. Genetic counseling explains inheritance, carrier testing, and the limits of predicting disease expression within families."
    },
    {
      "heading": "Prognosis",
      "text": "Severe central visual impairment often persists, but some individuals experience partial spontaneous recovery. Recovery may occur months or years after onset and does not necessarily restore normal vision.\n\nThe underlying variant is an important prognostic factor. Spontaneous recovery is generally more frequent with m.14484T>C than with m.11778G>A. Younger age at onset is also associated with more favorable outcomes in some studies. Differences in definitions of recovery and follow-up duration make precise comparisons between studies difficult."
    },
    {
      "heading": "Epidemiology and history",
      "text": "LHON is a rare disorder found across populations. Its measured prevalence varies geographically and depends on case ascertainment, founder effects, and whether studies count clinically affected individuals or all carriers of pathogenic variants.\n\nTheodor Leber described the characteristic familial optic neuropathy in 1871. In 1988, identification of the m.11778G>A mitochondrial DNA variant established a molecular basis for a major form of LHON and helped demonstrate the role of mitochondrial DNA variants in human disease.\n\nDespite the shared eponym, LHON is distinct from Leber congenital amaurosis, a group of inherited retinal disorders usually causing severe visual impairment from infancy or early childhood."
    }
  ],
  "links": [
    "mitochondrial-dna",
    "mutation",
    "enzyme",
    "adenosine-triphosphate",
    "diagnosis",
    "optical-coherence-tomography",
    "magnetic-resonance-imaging",
    "differential-diagnosis",
    "gene-therapy",
    "rehabilitation",
    "assistive-technology",
    "prevalence"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}